Results 161 to 170 of about 44,149 (263)
Targeted Delivery of mRNA to the Heart via Extracellular Vesicles or Lipid Nanoparticles. [PDF]
Nawaz M +13 more
europepmc +1 more source
Visualisation and Prediction of Phosphate Deficiency via Auto‐Glowing Plant Bioluminescent Sensors
Plant, Cell &Environment, EarlyView.
Ching‐Wen Chiu +12 more
wiley +1 more source
PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao +16 more
wiley +1 more source
A luminescent calcium biosensor enabling endpoint measurement of GPCR-mediated calcium signaling. [PDF]
Doi K +4 more
europepmc +1 more source
IL‐15‐engineered stem cell–NK cell complexes, assembled via bioorthogonal chemistry, enable effective lung cancer immunotherapy. Abstract Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation.
Qian Zhang +15 more
wiley +1 more source
Development of a Glymphatic Pathway-based Rat Model for Cancer Metastasis from Brain to Lung. [PDF]
Sreejith A +4 more
europepmc +1 more source
LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1
LMO7 in tumor‐associated macrophages suppresses phagocytosis of tumor cells and limits cytotoxic T lymphocytes infiltration, fostering tumor progression. Mechanistically, LMO7 mediates the ubiquitination and degradation of the phagocytic receptor LRP1, impairing its ability to engulf tumor cells and driving macrophages toward an antitumor phenotype ...
Mengkai Li +12 more
wiley +1 more source
This study developed a hierarchical targeting nanoplatform, siTREM2@ETP‐PEOz‐OMVs, against triple‐negative breast cancer (TNBC) bone metastasis. It precisely delivers therapeutic siTREM2 to monocytes/macrophages within the metastatic niche. This intervention dually regulates cell fate: reprogramming immunosuppressive macrophages and inhibiting ...
Fanglu Chen +12 more
wiley +1 more source
A Transgenic Mouse Model to Track MRC1-High Macrophages Using In Vivo Optical Imaging. [PDF]
Chawda C +6 more
europepmc +1 more source

